Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy

JAMA Cardiol. 2019 May 1;4(5):494. doi: 10.1001/jamacardio.2019.0546.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug-Eluting Stents*
  • Humans
  • Metals
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors
  • Stents

Substances

  • Metals
  • Platelet Aggregation Inhibitors